Pressmeddelanden från Integrum

Integrum Unveils Global Marketing Strategy at AOPA National Assembly

Mölndal, Sweden, September 4, 2025 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), the provider of the OPRA™ Implant Syste...

Cision • 04 Sep 16:23

Korrigering av uppgifter i delårsrapport för kvartalet maj-juni 2025/26

I samband med publiceringen av bolagets delårsrapport upptäcktes att några rader summerats fel i koncernens resultaträkning.

Cision • 01 Sep 13:16

Correction of Figures in Interim Report for the First Quarter 2025/26

When publishing the interim report for the company, it was discovered that some of the total sums in the income statement show the wrong amo...

Cision • 01 Sep 13:16

Stärkt positionering bäddar för fortsatt tillväxt

Första kvartalet 2025/26 (maj – juli) · Nettoomsättningen uppgick till 23,8 MSEK (18,5).

Cision • 01 Sep 07:15

Stronger positioning paves the way for continued growth

First quarter 2025/26 (May – July) · Net sales amounted to SEK 23.

Cision • 01 Sep 07:15

Integrum AB: Invitation to the First Quarter 2025/26 Results Presentation

Mölndal, Sweden – August 28, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its firs...

Cision • 28 Aug 14:52

Integrum AB: Inbjudan till presentation av Integrums första kvartal 2025/26

Mölndal, Sweden – Aug 28, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) kommer att hålla en webcastpresentation av rapp...

Cision • 28 Aug 14:52

Integrum publicerar årsredovisning 2024/25

Cision • 20 Aug 10:06

Integrum tar rollen som premiumsponsor för Global Collaborative Congress on Osseointegration de kommande tre åren

Mölndal, 13 augusti 2025 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att bolaget tar rollen som Legacy Sp...

Cision • 13 Aug 15:25

Integrum secures top sponsorship title at the Global Collaborative Congress on Osseointegration exclusively for the next three years

Mölndal, Sweden, August 13, 2025 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), the provider of the OPRA™ Implant System,...

Cision • 13 Aug 15:25

Statement by the independent bid committee of Integrum AB regarding the public takeover offer from OsteoCentric

The independent bid committee of Integrum AB has decided to recommend that the shareholders of Integrum AB accept OsteoCentric Oncology and ...

Cision • 22 Jul 07:13

Uttalande från Integrum AB:s oberoende budkommitté med anledning av det offentliga uppköpserbjudandet från OsteoCentric

Den oberoende budkommittén för Integrum AB har beslutat att rekommendera aktieägarna i Integrum AB att acceptera OsteoCentric Oncology and B...

Cision • 22 Jul 07:13

Integrum terminates agreement with Redeye regarding equity research coverage

Mölndal, Sweden, June 16, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has termina...

Cision • 16 Jun 14:39

Integrum avslutar avtal med Redeye om aktieanalysbevakning

Mölndal, Sverige, 16 juni 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att bolaget har avslutat sitt ...

Cision • 16 Jun 14:39

Integrum utser Louise Wåhlin till ny Chief Financial Officer

Mölndal, 16:e juni 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att Louise Wåhlin har utsetts till ny...

Cision • 16 Jun 09:00

Integrum appoints Louise Wåhlin as new Chief Financial Officer

Mölndal, Sweden, June 16[th], 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that Louise Wåhlin has b...

Cision • 16 Jun 09:00

A rapid shift to full commercial focus

Fourth quarter 2024/25 (February – April) · Net sales amounted to SEK 27.

Cision • 03 Jun 07:00

En snabb omställning till fullt kommersiellt fokus

Fjärde kvartalet 2024/25 (februari – april) · Nettoomsättningen uppgick till 27,1 MSEK (26,1).

Cision • 03 Jun 07:00

Integrum AB: Inbjudan till presentation av Integrums fjärde kvartal 2024/25

Mölndal, Sweden – Maj 30, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) kommer att hålla en webcastpresentation av rapp...

Cision • 30 May 11:35

Integrum AB: Invitation to the Fourth Quarter 2024/25 Results Presentation

Mölndal, Sweden – May 30, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its fourth ...

Cision • 30 May 11:35

Integrum har ingått ett avtal med Bionics Group Ukraine LLC för att bredda distributionen av OPRA[® ]Implant System i Ukraina

Mölndal, Sverige, 21 maj 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att bolaget har ingått ett avta...

Cision • 21 May 10:42

Integrum has signed an agreement with Bionics Group Ukraine LLC to enable a broadened distribution of OPRA® Implant System in Ukraine

Mölndal, Sweden, May 21, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has entered ...

Cision • 21 May 10:42

Integrum ingår kommersiellt distributionsavtal med Labormed för den slovenska marknaden

Mölndal, Sverige, 19 maj 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att bolaget har ingått ett komm...

Cision • 19 May 13:31

Integrum signs commercial distribution agreement with Labormed for the Slovenian market

Mölndal, Sweden, May 19, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has entered ...

Cision • 19 May 13:31

Integrum utser Martin Hillsten till ny vd

Mölndal, Sverige, 5 maj 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att Martin Hillsten har utsetts ...

Cision • 05 May 14:59

Integrum appoints Martin Hillsten as new Chief Executive Officer

Mölndal, Sweden, May 5, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces the appointment of Martin Hill...

Cision • 05 May 14:59

Integrum implementerar nytt kompensationspaket för vd

Mölndal, Sverige, 28 mars 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att bolaget har implementerat ...

Cision • 28 Mar 08:58

Integrum implements new compensation package for its CEO

Mölndal, Sweden, March 28 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has impleme...

Cision • 28 Mar 08:58

Integrums valberedning utsedd inför årsstämman 2025

Mölndal, 26 mars 2025 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att valberedningens ledamöter har utsetts ...

Cision • 26 Mar 10:00

Integrums OPRA[TM] Implant System visar överlägset behandlingsutfall i tvåårsuppföljning utförd av Walter Reed National Military Medical Center

Mölndal, 18 mars 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att en nyligen publicerad oberoende stu...

Cision • 18 Mar 14:57

Integrum’s OPRA[TM] Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center

Mölndal, Sweden, March 18, 2025 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) announces today that a newly published inde...

Cision • 18 Mar 14:57

Ett strategiskifte för att accelerera kommersialiseringen av implantatsystemet OPRA®

Tredje kvartalet 2024/25 (november–januari) · Nettoomsättningen uppgick till 23,7 (30,1) MSEK · Rörelseresultatet uppgick till -7,4 (0,...

Cision • 03 Mar 07:00

A strategic shift to accelerate the commercialization of OPRA® Implant System

Third quarter 2024/25 (November – January) · Net sales amount to 23.

Cision • 03 Mar 07:00

Integrum AB: Inbjudan till presentation av Integrums tredje kvartal 2024/25

Mölndal, Sweden – 27 februari, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) kommer att hålla en webcastpresentation av...

Cision • 28 Feb 10:07

Integrum AB: Invitation to the Third Quarter 2024/25 Results Presentation

Mölndal, Sweden – February 27, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its th...

Cision • 28 Feb 10:07

Integrum has carried out a directed new issue of 1,937,500 series B shares, raising proceeds of approximately SEK 31 million

Mölndal, Sweden – 18 February 2025 – The Board of Directors of Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or...

Cision • 18 Feb 22:00

Integrum har genomfört en riktad nyemission om 1 937 500 B-aktier och tillförs cirka 31 miljoner kronor

Mölndal, Sverige – 18 februari 2025 – Styrelsen i Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” eller “Bolaget”...

Cision • 18 Feb 22:00

Integrum utreder förutsättningarna för att genomföra en riktad nyemission av B-aktier om cirka 30 miljoner kronor

Mölndal, Sverige – 18 februari 2025 – Styrelsen i Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” eller “Bolaget”...

Cision • 18 Feb 17:39

Integrum explores the conditions to carry out a directed new issue of series B shares of approximately SEK 30 million

Mölndal, Sweden – 18 February 2025 – The Board of Directors of Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or...

Cision • 18 Feb 17:39

Integrum publishes preliminary revenue, result and cash flow figures for Q3, 2024/2025

Mölndal, Sweden – February 18, 2025 —Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today publishes its preliminary revenue,...

Cision • 18 Feb 17:32

Integrum publicerar preliminär omsättning, resultat och kassaflöde för Q3 2024/2025

Mölndal, – 18 februari 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) publicerar idag preliminära uppgifter om omsätt...

Cision • 18 Feb 17:32

Integrum genomför strategiskifte för att accelerera kommersialiseringen av OPRA® Implant System och uppnå kostnadseffektiviseringar på upp till 20 miljoner kronor årligen

Mölndal – 18 februari, 2025 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) presenterar idag ett strategiskifte för att accele...

Cision • 18 Feb 17:31

Integrum implements strategic shift to accelerate the commercialization of OPRA® Implant System and generate cost efficiencies up to SEK 20 million annually

Mölndal, Sweden – February 18, 2025 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces a strategic shift to accel...

Cision • 18 Feb 17:31

Integrum samarbetar med SPS för att bredda utbildningskalendern 2025 och förbättrar möjligheter till lärande

Integrum, kortnamn INTEG, det medicintekniska bolaget som tillhandahåller benförankrade OPRA® Implant System till amputerade, är stolta över...

Cision • 28 Jan 09:48

Integrum Partners with SPS to Expand 2025 Education Calendar, Enhancing Learning Opportunities

Integrum, ticker INTEG, the leader in innovative bone-anchored prosthetic solutions, is proud to announce the expansion of their 2025 Educat...

Cision • 28 Jan 09:48

Integrum välkomnar nya styrelseledamöter

Integrum AB (publ), kortnamn INTEG, det medicintekniska bolaget som tillhandahåller det benförankrade OPRA™ Implantat Systemet till amputera...

Cision • 21 Jan 21:31

Integrum welcomes new board members

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA implant system to amputees, welcomes t...

Cision • 21 Jan 21:19

Stämmokommuniké – Integrum AB

Integrum AB har den 20 januari 2025 hållit extra bolagsstämma.

Cision • 20 Jan 16:01

Integrum partners with Intelerad to Streamline Surgical Planning and Enhance Patient Outcomes in the US

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA® Implant System to amputees, partners ...

Cision • 15 Jan 14:00

Kallelse till extra bolagsstämma i Integrum AB

Aktieägarna i Integrum AB, org. nr 556407-3145 ("Bolaget"), kallas härmed till extra bolagsstämma den 20 januari 2025, kl.

Cision • 18 Dec 2024 22:14

The nomination committee in Integrum plans to propose the election of Anette Lindqvist as board member at an extraordinary general meeting

Integrum AB (publ), short name INTEG, the medical technology company that provides the bone-anchored OPRA™ Implant System to amputees, annou...

Cision • 18 Dec 2024 15:07

Valberedningen i Integrum planerar att föreslå nyval av Anette Lindqvist som styrelseledamot på extra stämma

Integrum AB (publ), kortnamn INTEG, det medicintekniska bolaget som tillhandahåller det benförankrade OPRA™ Implantat Systemet till amputera...

Cision • 18 Dec 2024 15:07

Enhanced Commercial Focus Leads to Rebound in Stage One Surgeries in the US

Second quarter 2024/25 (August – October) · Net sales amount to 21.

Cision • 04 Dec 2024 07:00

Ökat kommersiellt fokus leder till återhämtning av Steg 1 operationer i USA

Andra kvartalet 2024/25 (augusti – oktober) · Nettoomsättningen uppgick till 21,8 (27,6) MSEK, vilket är en minskning med 21,0 % jämfört ...

Cision • 04 Dec 2024 07:00

Integrum AB: Invitation to the Second Quarter 2024/25 Results Presentation

Mölndal, Sweden – November 29, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its se...

Cision • 29 Nov 2024 19:38

Integrum Launches Service Initiative to Strengthen U.S. Market Growth

Integrum AB (publ), ticker INTEG, a leader in medical technology and developer of the bone-anchored OPRA® Implant System, announces the laun...

Cision • 28 Nov 2024 10:59

Osseointegration for Amputees Makes its Education Forum Debut at OTA 2024

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA® Implant System to amputees announces ...

Cision • 31 Oct 2024 18:53

Ty Hanners appointed Director of Sales, US, focused on OPRA Implant System for Amputees

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA implant system to amputees, announces ...

Cision • 07 Oct 2024 15:02

Ty Hanners utsedd till försäljningschef i USA med fokus på OPRA-implantatsystem för amputerade

Integrum AB (publ), ticker INTEG, det medicintekniska bolaget som tillhandahåller det benförankrade OPRA-implantatsystemet till amputerade, ...

Cision • 07 Oct 2024 15:02

Årsstämmokommuniké – Integrum AB

Integrum AB har den 25 september 2024 hållit årsstämma.

Cision • 25 Sep 2024 17:47

Join Us for an Investor Update Online with our Acting CEO Scott Flora

Integrum AB (publ), the medical technology company that improves the lives of amputees, cordially invites you to an online investor informat...

Cision • 20 Sep 2024 15:44

Välkommen till investerarinformation online med vår nya tillförordnade VD Scott Flora

Integrum AB (publ), det medicintekniska företaget som förbättrar livet för amputerade, bjuder in till ett informationsmöte för investerare o...

Cision • 20 Sep 2024 15:44

Inger Rydin is appointed interim COO and takes office immediately

Integrum AB (publ), the medical technology company that improves the lives of amputees, announces that Inger Rydin has been appointed interi...

Cision • 17 Sep 2024 17:55

Inger Rydin utses till interim COO och tillträder omedelbart

Integrum AB (publ), det medicintekniska bolaget som förbättrar livet för amputerade, meddelar att Inger Rydin utses till interim COO och ans...

Cision • 17 Sep 2024 17:55

Styrelsen i Integrum utser Scott Flora till tillförordnad VD

Integrums VD Rickard Brånemark har idag tillsammans med styrelsen kommit överens om att han lämnar VD-rollen.

Cision • 15 Sep 2024 22:28

The board of Integrum appoints Scott Flora as acting CEO

Integrums CEO Rickard Brånemark has today agreed together with the board that he will leave the CEO role.

Cision • 15 Sep 2024 22:28

Integrum publicerar årsredovisning 2023/24

Integrum har idag publicerat Årsredovisning 2023/24 för räkenskapsåret 1 maj 2023 till 30 april 2024.

Cision • 04 Sep 2024 16:59

Focus on long-term growth creates setback in sales

FIRST QUARTER 2024/25 (MAY – JULY) · Net sales amounted to 18.

Cision • 29 Aug 2024 07:00

Fokus på långsiktig tillväxt leder till minskad omsättning

FÖRSTA KVARTALET 2024/25 (MAJ – JULI) · Nettoomsättningen uppgick till 18,5 (20,4) MSEK, vilket är en minskning med 9,5 % jämfört med mot...

Cision • 29 Aug 2024 07:00

Kallelse till årsstämma i Integrum AB

Aktieägarna i Integrum AB, org. nr 556407-3145 ("Bolaget"), kallas härmed till årsstämma den 25 september 2024, kl.

Cision • 27 Aug 2024 16:58

Integrum AB: Invitation to the First Quarter 2024/25 Results Presentation

Mölndal, Sweden – August 26, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its firs...

Cision • 26 Aug 2024 10:25

Integrum har genomfört en riktad nyemission om 961 539 B-aktier och tillförs cirka 50 miljoner kronor

Mölndal, Sverige – 13 juni 2024 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” eller “Bolaget”) har framgångsr...

Cision • 13 Jun 2024 22:25

Integrum has carried out a directed new issue of 961,539 series B shares, raising proceeds of approximately SEK 50 million

Mölndal, Sweden – 13 June 2024 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or the “Company”) has successful...

Cision • 13 Jun 2024 22:25

Integrum avser att genomföra en riktad nyemission av B-aktier om cirka 50 miljoner kronor

Mölndal, Sverige – 13 juni 2024 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” eller “Bolaget”) offentliggör a...

Cision • 13 Jun 2024 17:31

Integrum intends to carry out a directed new issue of series B shares of approximately SEK 50 million

Mölndal, Sweden – 13 June 2024 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or the “Company”) announces its ...

Cision • 13 Jun 2024 17:31

Integrum signs Memorandum of Understanding with Coapt for the use of its pattern recognition technology with the e-OPRA[TM] Implant System

Mölndal, Sweden – June 13, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has entered a Memor...

Cision • 13 Jun 2024 08:36

Integrum enters collaboration and distribution agreement with Hanger – the leading provider of amputee care and prosthetics in the US

Mölndal, Sweden – June 10, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has entered a...

Cision • 10 Jun 2024 17:16

A Record Year in Sales

FOURTH QUARTER 2023/24 (FEBRUARY – APRIL) · Net sales amount to 26.

Cision • 30 May 2024 07:00

Ett år med rekordomsättning

FJÄRDE KVARTALET 2023/24 (FEBRUARI – APRIL) · Nettoomsättningen uppgick till 26,1 (18,1) MSEK, vilket är en ökning med 43,7 % jämfört med...

Cision • 30 May 2024 07:00

Integrum receives market approval for OPRA[® in Israel]

Mölndal, Sweden – May 29, 2024 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has received market ...

Cision • 29 May 2024 16:21

Integrum AB: Invitation to the Fourth Quarter 2023/24 Results Presentation

Mölndal, Sweden – May 24, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its fourth ...

Cision • 24 May 2024 17:06

Integrum has been granted a registered trademark for OPRA® Implant System in the EU

Mölndal, Sweden – May 15, 2024 — Integrum (publ) (Nasdaq First North Growth Marketing: INTEG B) announces that the European Union Intellectu...

Cision • 15 May 2024 07:00

Integrum launches short video documentary to showcase the company’s efforts to treat combat amputees in Ukraine

Mölndal, Sweden – May 3, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company has launched a ...

Cision • 03 May 2024 07:39

Integrum expands its product offering to the United Kingdom market

Mölndal, Sweden – May 2, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has entered a commerc...

Cision • 02 May 2024 07:00

Integrum kommenterar nedstängningen av Center for Bionics and Pain Research

Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) kommenterar idag att Chalmers tekniska högskola, Göteborgs universitet och Sa...

Cision • 25 Apr 2024 17:17

Integrum expands its product offering into the Israeli market

Mölndal, Sweden – March 26, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has entered a comm...

Cision • 26 Mar 2024 07:00

Health economic study shows positive outcome using Integrum’s OPRA[TM] Implant System over socket prostheses in transfemoral amputees

Mölndal, Sweden – March 19, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that a team of independent research...

Cision • 19 Mar 2024 07:00

Integrums valberedning utsedd inför årsstämman 2024

Mölndal, 18 mars 2024 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) meddelar idag att valberedningens ledamöter har utsetts ...

Cision • 18 Mar 2024 16:06

Rättelse Ett nytt kvartal med rekordintäkter och 61 % tillväxt

Siffran för Nyttjanderätter (6 620 KSEK) saknades i den förra versionen och är nu tillagd.

Cision • 29 Feb 2024 09:39

CORRECTION A new record revenue quarter with 61% growth

The figures for Rights of Use assets (6,620 KSEK) were missing in the previous report and have now been added.

Cision • 29 Feb 2024 09:39

A new record revenue quarter with 61% growth

THIRD QUARTER 2023/24 (NOV – JAN) · Net sales amounts to 30.

Cision • 29 Feb 2024 07:00

Ett nytt kvartal med rekordintäkter och 61 % tillväxt

TREDJE KVARTALET 2023/24 (NOV – JAN) · Nettoomsättningen uppgick till 30,1 (18,7) MSEK, vilket är en ökning med 61 % jämfört med motsvara...

Cision • 29 Feb 2024 07:00

Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation

Mölndal, Sweden – February 23, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its th...

Cision • 23 Feb 2024 09:26

Integrum has sold and delivered OPRA[TM] Implant Systems to a value of SEK 3.5 million to Center of Excellence in Ukraine

Mölndal, Sweden – January 31, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company today has sold a...

Cision • 31 Jan 2024 23:31

Integrum establishes Center of Excellence in Ukraine

Mölndal, Sweden – December 20, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has estab...

Cision • 20 Dec 2023 08:41

Integrum’s MDR certification is completed for the OPRA[TM] Implant System

Mölndal, Sweden – December 15, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has recei...

Cision • 15 Dec 2023 09:05

Record sales and profitability

SECOND QUARTER 2023/24 (MAY – JULY) · Net sales amounted to SEK 27.

Cision • 04 Dec 2023 08:30

Rekordförsäljning och lönsamhet

ANDRA KVARTALET 2023/24 (AUG–OKT) · Nettoomsättningen uppgick till 27,6 (20,2) MSEK, vilket är en ökning med 36 % jämfört med motsvarande...

Cision • 04 Dec 2023 08:30

Integrum AB changes Certified Adviser to Carnegie Investment Bank AB (publ)

Mölndal, Sweden – November 30, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces a change of Certified Advi...

Cision • 30 Nov 2023 09:46

Integrum AB: Invitation to the Second Quarter 2023/24 Results Presentation

Mölndal, Sweden – November 28, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its se...

Cision • 28 Nov 2023 11:45